Literature DB >> 7554316

Impaired social status of growth hormone deficient adults as compared to controls with short or normal stature. Dutch Growth Hormone Working Group.

B Rikken1, J van Busschbach, S le Cessie, W Manten, T Spermon, R Grobbee, J M Wit.   

Abstract

OBJECTIVES: In adults with growth hormone deficiency (GHD) social problems have been reported, but so far the relative contributions of GHD, additional pituitary deficiencies and short stature have not been distinguished. We therefore compared social data from GHD patients with social data from controls with short or normal stature. Furthermore we investigated whether social problems are caused solely by the deficiency of GH or also by the associated absence of other pituitary hormones.
DESIGN: A questionnaire was sent to patients and controls with items on education, profession, income, partner and living situation. PATIENTS: Two hundred and ten GHD patients treated in childhood but not in adulthood with GH (93 isolated GHD (IGHD), 111 patients with multiple pituitary deficiency (MPD)) were compared with 53 short controls (height in childhood < third percentile for population) and 39 normal stature controls.
RESULTS: There were no differences between short and normal controls. There were also no differences between IGHD and MPD patients in any of the investigated items. GHD patients did not differ from controls on education level, but scored lower on the profession scale, had a lower income and had a partner less often; if they had a partner they less often had children; also, more of them lived with their parents.
CONCLUSION: Since patients with multiple pituitary deficiency did not differ from patients with isolated growth hormone deficiency, this suggests that the lower scores on the social parameters are the result of the growth hormone deficiency itself. Since short stature controls had higher scores than patients with growth hormone deficiency and did not differ from normal stature controls in any of the aspects investigated, it seems unlikely that the problems of the patients with growth hormone deficiency can be attributed to short stature.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554316     DOI: 10.1111/j.1365-2265.1995.tb01916.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  Growth hormone, prolactin, and sexuality.

Authors:  M Galdiero; R Pivonello; L F S Grasso; A Cozzolino; A Colao
Journal:  J Endocrinol Invest       Date:  2012-09       Impact factor: 4.256

Review 2.  A risk-benefit assessment of growth hormone use in children.

Authors:  S L Blethen; M H MacGillivray
Journal:  Drug Saf       Date:  1997-11       Impact factor: 5.606

Review 3.  [Growth hormone therapy in adults. Attempt to assess a decade of use].

Authors:  M Faust; C J Strasburger
Journal:  Internist (Berl)       Date:  2008-05       Impact factor: 0.743

Review 4.  Diagnosis and management of adult growth hormone deficiency.

Authors:  K K Ho
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.925

Review 5.  Growth hormone therapy in childhood-onset growth hormone deficiency: adult anthropometric and psychological outcomes.

Authors:  D E Sandberg; M H MacGillivray
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.925

6.  Differential effect sizes of growth hormone replacement on Quality of Life, well-being and health status in growth hormone deficient patients: a meta-analysis.

Authors:  Jan Berend Deijen; Lucia I Arwert; Joost Witlox; Madeleine L Drent
Journal:  Health Qual Life Outcomes       Date:  2005-10-19       Impact factor: 3.186

Review 7.  Possible effects of an early diagnosis and treatment in patients with growth hormone deficiency: the state of art.

Authors:  Stefano Stagi; Perla Scalini; Giovanni Farello; Alberto Verrotti
Journal:  Ital J Pediatr       Date:  2017-09-16       Impact factor: 2.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.